Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs April 11, 2016 FDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet… December 27, 2017 3 Things to Watch Out in Illumina's Q4 January 29, 2017
Sweden's Lipigon Inks $100 Million Pact with Drug Giant AstraZeneca PLC to Identify New Cholesterol Drugs April 11, 2016
FDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet… December 27, 2017
